87
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The oncological outcome and influence of neoadjuvant chemotherapy on the surgery in the resectable and locally advanced oral squamous cell carcinoma

, , , , , & show all
Pages 7039-7046 | Published online: 25 Jul 2019

References

  • Ow TJ, Myers JN. Current management of advanced resectable oral cavity squamous cell carcinoma. Clin Exp Otorhinolaryngol. 2011;4:1–10. doi:10.3342/ceo.2011.4.1.121461056
  • Amit M, Yen TC, Liao CT, et al. Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study. Cancer. 2013;119:4242–4248. doi:10.1002/cncr.2835724114787
  • Devisetty K, Wong SJ. Neoadjuvant versus induction chemotherapy: more than semantics. J Clin Oncol. 2013;31:2971–2972. doi:10.1200/JCO.2013.50.2674
  • Garden AS. The never-ending story: finding a role for neoadjuvant chemotherapy in the management of head and neck cancer. J Clin Oncol. 2014;32:2685–2686. doi:10.1200/JCO.2014.56.768525049324
  • Spiotto MT. Return of induction chemotherapy in head and neck squamous cell cancers: is this time different? Lancet Oncol. 2016;17:1465–1467. doi:10.1016/S1470-2045(16)30444-227686944
  • Forastiere AA, Adelstein DJ, Manola J. Induction chemotherapy meta-analysis in head and neck cancer: right answer, wrong question. J Clin Oncol. 2013;31:2844–2846. doi:10.1200/JCO.2013.50.313623835711
  • Chinn SB, Spector ME, Bellile EL, et al. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma. JAMA Otolaryngol Head Neck Surg. 2014;140:134–142. doi:10.1001/jamaoto.2013.589224370563
  • Zhong L-P, Zhang C-P, Ren G-X, et al. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 2013;31:744–751. doi:10.1200/JCO.2012.43.882023129742
  • Bossi P, Lo Vullo S, Guzzo M, et al. Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial. Ann Oncol. 2014;25:462–466. doi:10.1093/annonc/mdt55524401930
  • Cohen EE, Karrison TG, Kocherginsky M, et al. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol. 2014;32:2735–2743. doi:10.1200/JCO.2013.54.630925049329
  • Haddad R, O’Neill A, Rabinowits G, et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol. 2013;14:257–264. doi:10.1016/S1470-2045(13)70011-123414589
  • Lefebvre JL, Pointreau Y, Rolland F, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol. 2013;31:853–859. doi:10.1200/JCO.2012.42.398823341517
  • Yang WC, Chen CH, Tang JY, et al. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma. Anticancer Res. 2014;34:3765–3773.24982400
  • Won HS, Lee YS, Jeon EK, et al. Clinical outcome of induction chemotherapy in locally advanced head and neck squamous cell carcinoma. Anticancer Res. 2014;34:5709–5714.25275078
  • Kies MS, Boatright DH, Li G, et al. Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults. Head Neck. 2012;34:1255–1262. doi:10.1002/hed.2190622009800
  • Perrone F, Bossi P, Cortelazzi B, et al. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma. J Clin Oncol. 2010;28:761–766. doi:10.1200/JCO.2009.22.417020048189
  • Lee JJ, Hah JH, Im SA, et al. Neoadjuvant chemotherapy followed by limited surgery in a mouse model of head and neck cancer. Anticancer Res. 2009;29:255–259.19331158